EDGAR Filing Documents for 0001209191-17-027841

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-17-027841

Filing Date

2017-04-21

Accepted

2017-04-21 16:34:57

Documents

Period of Report

2017-04-19

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	6397
	Complete submission text file	0001209191-17-027841.txt		7898

Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025

Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269

Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INOTEK PHARMACEUTICALS CORPORATION 131 HARTWELL AVENUE, SUITE 105 LEXINGTON MA 02421

Business Address

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 17776302